Sarepta Therapeutics, Inc. with ticker code (SRPT) now have 19 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 218 and 139 calculating the mean target price we have $175.68. Now with the previous closing price of $157.19 this indicates there is a potential upside of 11.8%. The day 50 moving average is $133.09 while the 200 day moving average is $120.85. The company has a market capitalization of 13.89B. The stock price for Rocket Companies, Inc. is 149.14 USD
The potential market cap would be $15,526,313,601 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 11.11 and a -11.88% return on assets.
